Stock Symbol:   

Stoxline Mobile
Home  |  Stock Charts  |  Showcases  |  Stock Ranks  |  Options  |  ETFs  |  Educations

MiMedx Group Inc. (MDXG)

2.65   -0.06 (-2.21%) 01-23 15:59
Open: 0 Pre. Close: 2.71
High: 0 Low: 0
Volume: 0 Market Cap: 294M

Stock Price Prediction

Update at 5:00pm EST
If tomorrow: Open lower Open higher
High: 2.853 - 2.869 2.869 - 2.884
Low: 2.555 - 2.572 2.572 - 2.587
Close: 2.626 - 2.653 2.653 - 2.677

Technical analysis

as of: 2019-01-23 4:29:18 PM
Stoxline posted a NEUTRAL today, downgraded from higher rating. Current trend continues, but could change at anytime. It is not a good time to buy or sell.
Target: Six months: 3.56     One year: 4.16
Support: Support1: 1.98    Support2: 1.32
Resistance: Resistance1: 3.05    Resistance2: 3.56
Pivot: 2.38
Moving Average: MA(5): 2.56     MA(20): 2.17
MA(100): 3.91     MA(250): 5.98
MACD: MACD(12,26): 0.09     Signal(9):
Stochastic oscillator: %K(14,3): 76.16     %D(3): 76.36
RSI: RSI(14): 59.66
52-week: High: 18.25  Low: 0.95  Change(%): -82.4
Average Vol(K): 3-Month: 488655  10-Days: 162237

Price, moving averages and Bollinger Bands

Price and moving averages has closed above its Short term moving average. Short term moving average is currently above mid-term; AND below long term moving averages. From the relationship between price and moving averages; we can see that: This stock is BULLISH in short-term; and NEUTRAL in mid-long term.
MDXG has closed below upper band by 21.0%. Bollinger Bands are 57% narrower than normal. The narrow width of the bands suggests low volatility as compared to MDXG's normal range. The bands have been in this narrow range for 2 bars. This is a sign that the market may be about to initiate a new trend.

Headline News

MasTec +5.2% on move to MidCap 400; FTK -4.1% on exiting SmallCap 600

Jack Henry & Associates Set to Join S&P 500; EQT, Equitrans Midstream, MasTec to Join S&P MidCap 400; Superior Energy Services, United Natural Foods to Join S&P SmallCap 600

Tech and consumer goods stock down in premarket trade

MiMedx institutes poison pill to thwart potential takeover; shares down 33% premarket

MiMedx down 23% premarket on delisting notice

MiMedx Adopts Limited Duration Shareholder Rights Plan In Response To Delisting From Nasdaq

MiMedx Receives Nasdaq Delisting Notification

Financial Analysis

Growth measures the growth of both a company's revenue and net income. it tells investors how fast a company is growing.
Profitability measures a company’s ability to generate earnings as compared to its expenses and other relevant costs.
Solvency measures a company's ability to meet its long-term debts. Acceptable solvency ratios will vary from industry to industry.
Efficiency measures the strength of a company's return on invested capital. It can identify business that are better managed or not.
Click here to get more fundamental analysis.
Tweet this page Share on Google+ Share on Facebook
Free Technical Analysis Charts

Stock Basics & Statistics

Sector:  Healthcare
Industry:  Medical Devices
Shares Out. (M) 111.03
Shares Float (M) 97.51
% Held by Insiders
% Held by Institutions 50.30
Shares Short (K)
Shares Short P. Month (K)

Stock Financials

EPS 0.050
EPS Est. Current Year 0.310
EPS Est. Next Year 0.400
EPS Est. Next Quarter 0.090
Forward EPS 0.460
Book Value (p.s.) 4.850
PEG Ratio 0.48
Profit Margin
Operating Margin 10.63
Return on Assets (ttm) 19.2
Return on Equity (ttm) 26.0
Qtrly Rev. Growth 31.3
Gross Profit (p.s.) 0.675
Sales Per Share
EBITDA (p.s.) 0.093
Qtrly Earnings Growth 425.70
Operating Cash Flow (M) 58.75
Levered Free Cash Flow (M) 43.51

Stock Valuations

P/E 53.00
P/E Growth Ratio -0.02
P/BV 0.55
P/S 103238424.00
P/CF 5.01

Dividends & Splits

Dividend Yield
Dividend Pay Date Invalid DateTime.
Ex-Dividend Date Invalid DateTime.
Forward Dividend
Last Split Date
Last Split Ratio -1e+010
7 Binary Options
Your Ad Here
Stock Chart
Stoxline Lite
Stoxline Pro
Option Calculator
(c) 2006-2019 | Contact us           
Data and information is provided for informational purposes only, and is not intended for trading purposes. Neither nor its data provider shall be liable for any errors or delays in the content, or for any actions taken in reliance thereon. By accessing the web site, a user agrees not to redistribute the information found therein.